While these models provide valuable insights into the specific contributions of NO and NOS isoforms, it is essential to extend the research to animal models of aging [33,36,60,61] and models that mimic various cardiovascular risk factors, such as diabetes and metabolic disease, which are known to be characterized by endothelial dysfunction and impaired NO bioavailability [43]. Here, NOS1 is linked to Other metabolic disease.